“Stem cell derived live cells for medical treatments are fundamental science supporting the future of healthcare. Imagine a world soon when lab generated cells can replace pancreatic cells to ‘cure’ Type 1 diabetes, ‘regrow’ damaged or cancerous organs and provide us with an anti-aging opportunity to regrow hair and renew our skin to it’s younger years. The future is now, and Acorn is leading the way.”

Elaine Chin, M.D., M.B.A.

Precision Medicine Physician Chief Medical Officer, Executive Health Centre Founder, Innovation Health Group

During my medical training, we were taught cryopreservation, regenerative medicine and personalized genomics, but there were no tangible solutions for patients. Now, with Acorn, patients are able to save a sample of their cells today to have access to the next generation of healthcare. I am already excited by all of the amazing work that Acorn has achieved, and there is still so much to come.

Dr. Patrick Galange, MD, MBA, CCFP

Assistant Clinical (Adjunct) Professor, McMaster University

"For the Toronto-based company, the pitch isn’t just around banking genetic material…. It’s about making that process cheaper and easier."

Tech Crunch

"Acorn’s method allows for full genome collection without the need for surgery or other invasive procedures, aiming to make stem cell collection significantly more affordable and accessible."

Betakit